Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focus on clozapine.

M Naheed1, B Green

  • 1Hollins Park Hospital, Warrington, Cheshire, UK.

Current Medical Research and Opinion
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Clozapine, an atypical antipsychotic, effectively treats resistant schizophrenia through dopaminergic and serotonergic pathways. However, its use is restricted due to the risk of agranulocytosis, a serious blood disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic stress disorder cases reported by UK occupational physicians 1996-2024.

Occupational medicine (Oxford, England)·2026
Same author

Spinal Epidural Abscess Without Fever: Challenging the Classic Triad.

Irish medical journal·2024
Same author

Comparison of the survival of different isolates of SARS-CoV-2 in evaporating aerosols.

Aerosol science and technology : the journal of the American Association for Aerosol Research·2023
Same author

Pulse- and field-resolved THz-diagnostics at 4 <sup></sup> generation lightsources.

Optics express·2019
Same author

Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

Scientific reports·2019
Same author

On-chip THz spectrometer for bunch compression fingerprinting at fourth-generation light sources.

Journal of synchrotron radiation·2018
Same journal

Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study.

Current medical research and opinion·2026
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Clozapine is a dibenzodiazepine derivative with atypical antipsychotic properties.
  • Its therapeutic mechanisms are linked to dopaminergic and serotonergic activity.
  • It is recognized as highly effective for treatment-resistant schizophrenia.

Purpose of the Study:

  • To review the efficacy and limitations of clozapine in treating schizophrenia.

Main Methods:

  • Literature review of pharmacological and clinical studies on clozapine.
  • Analysis of mechanisms of action, focusing on neurotransmitter systems.
  • Evaluation of clinical outcomes in treatment-resistant schizophrenia populations.

Main Results:

Related Experiment Videos

  • Clozapine demonstrates significant efficacy in patients with schizophrenia unresponsive to other treatments.
  • Therapeutic effects are associated with modulation of dopamine and serotonin receptors.
  • A major limitation is the potential risk of agranulocytosis, a severe adverse effect.

Conclusions:

  • Clozapine remains a crucial option for treatment-resistant schizophrenia.
  • Careful patient monitoring is essential to mitigate the risks associated with clozapine therapy.
  • Balancing efficacy and safety is key in the clinical application of clozapine.